Popular Articles
Natural Remedies

Who Director General Calls For Fairness In International Policies
New York: With a growing recognition that "blind faith in economic growth and gain as the be-all, end-all, cure-for-all has been misplaced," World Health Organization Director-General Dr Margaret Chan responded to leaders who have been calling for a redesign of international systems.
generic viagra online
Competitive Technologies' Pain Therapy Medical Device To Be Used In Independent Clinical Study
Competitive Technologies, Inc. (NYSE Amex: CTT) announced today that CTT"s pain therapy medical device will be used by clinical investigators at the Virginia Commonwealth University Massey Cancer Center for a Phase II independent clinical study. The study will examine the ability of CTT"s U.S. FDA-cleared device to decrease pain associated with chemotherapy-induced peripheral neuropathy (CIPN).
News of the day
Patients With Moderate To Severe Periodontitis Need Evaluation For Heart Disease Risk
Additional research is called for and patients with moderate to severe periodontitis should receive evaluation and possible treatment to reduce their risk of atherosclerotic cardiovascular disease (CVD), according to a special consensus paper by editors of The American Journal of Cardiology and Journal of Peridontology in the July 1, 2009 issue of The American Journal of Cardiology, published by Elsevier.
Diagnostics

National Pharmacy Association Calls For Zero Increase In RPSGB Retention Fees - UK

The NPA is asking for the RPSGB retention fee to be held at the present level, given the financial pressures on pharmacy businesses, many of which pay retention fees for their staff. Margaret Peycke, NPA External Relations Manager said: "The justification to charge RPSGB members more is unclear, especially as such a large increase in fees (40%) was made in 2008, the declared purpose of which was to provide the RPSGB with the res to create the regulatory and professional leadership bodies. In such circumstances, an uplift to fees in the region of 2.2% is inappropriate." "NPA members already coping with a challenging economic environment are not in a position to comfortably absorb such increases, bearing in mind that many employers fund their employee pharmacist and technician retention fees. The NPA has recently surveyed its members and over 80% highlighted the current burden of costs on their pharmacy business." In addition the fee set by the RPSGB is a fee which will be divided between the new regulatory body (GPhC) and the new professional leadership body (PLB) after the split which is due to occur in April 2010. The document does not indicate how the fees will be apportioned between the bodies or make mention of the fact that existing members of RPSGB who do not wish to join the new PLB do not have to and will be entitled to a refund on the unused element of the fees apportioned to the PLB. National Pharmacy Association


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):